Convenient and time-saving reaction set-up with abm’s cDNA Synthesis SuperMix. abm’s cDNA Synthesis SuperMix provides highly efficient and specific conversion of RNA to cDNA, even from low-abundance transcripts. Furthermore, the unique blend of random primers and oligo(dT) primers in this SuperMix ensures optimal representation of all transcript sequences in the cDNA product. Overall, abm’s cDNA Synthesis SuperMix allows you to perform first-strand cDNA synthesis with minimal effort and maximum ease.
Key Features
• Streamlined protocol suitable for high-throughput applications
• Ease of use with a simple set-up
• Excellent cDNA yield
This SuperMix contains abm's EasyScript™ Plus Reverse Transcriptase .
Template
RNA
Trade Marker
OneScript®
Format
SuperMix
Quantity
100 x 20 µl reactions
Reaction
RT-PCR
Reference
Amodio, G et al. "Identification of a microRNA (miR-663a) induced by ER stress and its target gene PLOD3 by a combined microRNome and proteome approach." Cell Bio. Toxicol. 4:285-303 (2016). DOI: 10.1007/s10565-016-9335-z.
Chung, G et al. "CHL-1 provides an essential function affecting cell proliferation and chromosome stability in Caenorhabditis elegans." DNA Repair (Amst.) 10 (11):1174- 1182 (2011). DOI: 10.1016/j.dnarep.2011.09.011. PubMed: 21968058. Application: PCR.
Jones, MR et al. "The atm-1 gene is required for genome stability in Caenorhabditis elegans." Mol. Genet. Genomics 287 (4):325-335 (2012). DOI: 10.1007/s00438-012-0681-0. PubMed: 22350747. Application: PCR.
Kim, BH et al. "Sophoraflavanone G induces apoptosis of human cancer cells by targeting upstream signals of STATs." Biochem. Pharmacol. 86 (7):950-959 (2013). DOI: 10.1016/j.bcp.2013.08.009. PubMed: 23962443. Application: Reverse Transcription.
Lee, G et al. "Potential monoclonal antibody therapy for the treatment of ovarian cancer." Ovarian cancer—basic science perspective :385-406 (2012). DOI: 10.5772/1268 . Application: Reverse Transcription.
Meng, X et al. "Rapid and efficient reprogramming of human fetal and adult blood CD34+ cells into mesenchymal stem cells with a single factor." Cell Res. 23:658-672 (2013). DOI: 10.1038/cr.2013.40. Application: Reverse Transcription.
Unsoy, G et al. "Chitosan magnetic nanoparticles for pH responsive Bortezomib release in cancer therapy." Biomedicine & Pharmacotherapy 68(5):641-649 (2014). DOI: 10.1016/j.biopha.2014.04.003. PubMed: 24880680. Application: Reverse Transcription.